7,853 reports of this reaction
17.9% of all AFLIBERCEPT reports
#1 most reported adverse reaction
DEATH is the #1 most commonly reported adverse reaction for AFLIBERCEPT, manufactured by Regeneron Pharmaceuticals, Inc.. There are 7,853 FDA adverse event reports linking AFLIBERCEPT to DEATH. This represents approximately 17.9% of all 43,844 adverse event reports for this drug.
Patients taking AFLIBERCEPT who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is a frequently reported adverse event for AFLIBERCEPT, accounting for a significant proportion of all reports.
In addition to death, the following adverse reactions have been reported for AFLIBERCEPT:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 7,853 FDA reports for AFLIBERCEPT. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 17.9% of all adverse event reports for AFLIBERCEPT, making it one of the most commonly reported side effect.
If you experience death while taking AFLIBERCEPT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.